| Ibrutinib in treatment of mantle cell lymphoma with IGHV non-mutated and bone marrow metastatic: report of two cases |
| Received:April 15, 2021 Revised:June 25, 2021 Click here to download the full text |
| Citation of this paper:LI Jin-yin,JIA Rong-fei,JIANG Ling,HOU An-ji,LI Bin,YANG Xiao-yan.Ibrutinib in treatment of mantle cell lymphoma with IGHV non-mutated and bone marrow metastatic: report of two cases[J].Chinese Journal of Clinical Medicine,2021,28(6):1086-1091 |
| Hits: 1127 |
| Download times: 234 |
| Author Name | Affiliation | E-mail | | LI Jin-yin | Department of Pharmacy, Shanghai Xuhui Central Hospital, Shanghai 200031, China | | | JIA Rong-fei | Department of Oncology, Shanghai Xuhui Central Hospital, Shanghai 200031, China | | | JIANG Ling | Department of Oncology, Shanghai Xuhui Central Hospital, Shanghai 200031, China | | | HOU An-ji | Department of Oncology, Shanghai Xuhui Central Hospital, Shanghai 200031, China | | | LI Bin | Department of Pathology, Shanghai Xuhui Central Hospital, Shanghai 200031, China | | | YANG Xiao-yan | Department of Oncology, Shanghai Xuhui Central Hospital, Shanghai 200031, China | yang_xiaoyan73@163.com |
|
| keywords:ibrutinib mantle cell lymphoma gene detection |
| HTML View Full Text View/Add Comment Download reader |
|
|
|